Division of Pharmacogenomics

Medicine & Life Sciences

1. Cardiac Myocytes 100%
2. Heart Failure 73%
3. Mitochondrial Dynamics 72%
4. Heart 71%
5. Cardiomyopathies 52%
6. Mitochondria 50%
7. Hypertrophy 50%
8. Cardiomegaly 47%
9. Adrenergic Receptors 40%
10. Mitophagy 39%
11. G-Protein-Coupled Receptor Kinase 2 36%
12. Prostaglandin H2 Receptors Thromboxane A2 35%
13. Protein Kinase C 35%
14. Sarcoplasmic Reticulum 32%
15. Genes 30%
16. phospholamban 29%
17. Transgenic Mice 27%
18. MicroRNAs 25%
19. Apoptosis 23%
20. Thromboxane A2 23%
21. Type 2A Charcot-Marie-Tooth disease 23%
22. Heart Diseases 23%
23. Dilated Cardiomyopathy 20%
24. Vascular Smooth Muscle 20%
25. Blood Platelets 19%
26. Muscle Cells 19%
27. Methylation 19%
28. Gene Expression 18%
29. DNA Methylation 18%
30. Calcium 18%
31. Phenotype 17%
32. Autophagy 17%
33. Proteins 17%
34. Phosphorylation 16%
35. Adrenergic Agents 16%
36. Mutation 16%
37. Messenger RNA 15%
38. Quality Control 15%
39. Cell Death 14%
40. Single Nucleotide Polymorphism 14%
41. Myocardial Infarction 14%
42. Growth 14%
43. Ventricular Remodeling 13%
44. Mitochondrial Proteins 12%
45. Organelles 12%
46. Thromboxane Receptors 12%
47. Genome 12%
48. 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid 12%
49. Myocardium 12%
50. Prostaglandin H2 12%
51. DNA 11%
52. Phosphotransferases 11%
53. Drosophila 11%
54. Pressure 10%
55. Cyclic GMP-Dependent Protein Kinases 10%
56. Thromboxanes 10%
57. Ischemia 9%
58. Protein Isoforms 9%
59. Smooth Muscle Myocytes 9%
60. African Americans 9%
61. Necrosis 9%
62. Myosin Heavy Chains 8%
63. Organelle Biogenesis 8%
64. DNA Sequence Analysis 8%
65. Reactive Oxygen Species 8%
66. High-Throughput Nucleotide Sequencing 8%
67. Adenylyl Cyclases 8%
68. Fibroblast Growth Factor 2 8%
69. Homeostasis 8%
70. Endoplasmic Reticulum 8%
71. Fibrosis 8%
72. Dideoxynucleotides 8%
73. Therapeutics 8%
74. 7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid 7%
75. Fibroblasts 7%
76. Type C Phospholipases 7%
77. Pharmacogenetics 7%
78. human PPP1R2C protein 7%
79. Membranes 7%
80. Mortality 7%
81. Epigenomics 7%
82. Ligands 7%
83. Mitochondrial Diseases 7%
84. Down-Regulation 7%
85. Genotype 7%
86. Binding Sites 7%
87. RNA 6%
88. Mass Spectrometry 6%
89. Mitochondrial Transmembrane Permeability-Driven Necrosis 6%
90. In Vitro Techniques 6%
91. Pharmacology 6%
92. Dilatation 6%
93. Cardiovascular Diseases 6%
94. Calsequestrin 6%
95. GTP Phosphohydrolases 6%
96. Reperfusion Injury 6%
97. Calcineurin 6%
98. mitochondrial permeability transition pore 6%
99. RNA Sequence Analysis 6%
100. Nucleotides 6%